Effect of advanced glycosylation end products (AGEs) on proliferation of human bone marrow mesenchymal stem cells (MSCs) in vitro
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of advanced glycosylation end products (AGEs) on proliferation of human bone marrow mesenchymal stem cells (MSCs) in vitro
Authors
Keywords
-
Journal
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
Volume 48, Issue 9, Pages 599-602
Publisher
Springer Nature
Online
2012-10-10
DOI
10.1007/s11626-012-9551-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells
- (2010) Ke Yang et al. Cardiovascular Diabetology
- Diabetes Induced Changes in Rat Mesenchymal Stem Cells
- (2010) Alexandra Stolzing et al. CELLS TISSUES ORGANS
- The Promise of Cell-Based Therapies for Diabetic Complications
- (2010) Yagna P.R. Jarajapu et al. CIRCULATION RESEARCH
- Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes
- (2009) L. Vija et al. DIABETES & METABOLISM
- Trafficking and differentiation of mesenchymal stem cells
- (2009) Zhao-Jun Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress
- (2009) Jianfei Chen et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity
- (2009) H. C. Quevedo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and Humans
- (2009) Lingyun Sun et al. STEM CELLS
- Bone Marrow–Derived Mesenchymal Stem Cells Improve Islet Graft Function in Diabetic Rats
- (2009) M. Figliuzzi et al. TRANSPLANTATION PROCEEDINGS
- Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways
- (2008) Chengbo Sun et al. BASIC RESEARCH IN CARDIOLOGY
- Advanced glycation end products and diabetic foot disease
- (2008) Maya S.P. Huijberts et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
- (2008) Su-Yen Goh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cell-Based Therapy of Myocardial Infarction
- (2007) Stefanie Dimmeler et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression
- (2007) Sho-ichi Yamagishi et al. MICROVASCULAR RESEARCH
- Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes
- (2007) Veronika S. Urbán et al. STEM CELLS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started